Important: This product is not authorized for administration until further notice by the FDA.
Labeler
Vaccine Procedure
Payment Allowance
Effective From
Effective To
Footnotes
My Fee
GSK
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring
$450.00
2021-05-26
TBD
[3][10]
(your fee)
[3] These rates will be geographically adjusted for many providers.
[10] On April 5, 2022, the FDA announced that, due to the high frequency of the Omicron BA.2 sub-variant, this product isn’t currently authorized in any U.S. region and may not be administered to treat COVID-19 until further notice by the FDA.
Quick, Current, Complete - www.findacode.com